Written Question·Department of Health and Social Care·UIN 7179

Pancreatic Enzyme Replacement Therapy

Tabled: 4 October 2024
Answered: 11 October 2024

Question

Alison Hume

LabourScarborough and Whitby

To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure the adequacy of patient access to (a) Creon and (b) other pancreatic enzyme replacement medications; and whether he has had recent discussions with (i) NHS En

Answer

Karin Smyth
The Department has been working with suppliers to address current supply issues with Creon, which is used by patients with conditions such as cystic fibrosis and certain cancers including pancreatic cancer. The supply issues with Creon are impacting count...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 7179) →